In the BioHarmony Drug Report Database
Pretomanid
Pretomanid, Dovprela, Pretomanid FGK (pretomanid) is a small molecule pharmaceutical. Pretomanid was first approved as Pretomanid on 2019-08-14. It is used to treat extensively drug-resistant tuberculosis in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis.
Trade Name
|
Dovprela, Pretomanid FGK |
|---|---|
Common Name
|
pretomanid |
ChEMBL ID
|
CHEMBL227875 |
Indication
|
extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis |
Drug Class
|
Mycolic acid inhibitors |
Image (chem structure or protein)